Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUARDIAN Trial Induction Agent Sub-Study
NCT04934683Phase 4Enrolling by invitation
- Sponsor
- UTHealth Houston
- Start
- Jul 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of etomidate, propofol in major surgery, sponsored by UTHealth Houston. Started Jul 2021; status: enrolling by invitation.
02
Drugs
etomidatepropofol
03
Conditions
major surgery
Beyond the preview
Go deeper on NCT04934683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04934683.